Raymond James Financial’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$394K Buy
277,259
+26,454
+11% +$37.6K ﹤0.01% 4118
2025
Q1
$384K Buy
250,805
+96,454
+62% +$148K ﹤0.01% 4051
2024
Q4
$383K Buy
+154,351
New +$383K ﹤0.01% 4026